What causes Scleredema?
Febrile illness with streptococcal infections [8, 9] : An upper respiratory tract infection (typically pharyngitis) is the most common cause of scleredema in patients with type 1 scleredema. Scleredema following scabies infestation, as a result of superinfection with Streptococcus, has been reported.
Is Scleromyxedema an autoimmune disease?
Scleromyxedema (SM) is a rare disorder which initially presents with waxy skin stiffness and maculopapular lesions. It also has non-dermatologic manifestations, such as serum paraproteinemia and myopathies, and is sometimes associated with other autoimmune disorders.
What is best hospital to treat scleroderma?
The Johns Hopkins Scleroderma Center is one of the largest and most active in the world, seeing over 200 new patients each year.
How do you treat Scleredema?
Treating Scleroderma
- Getting pain relief through nonsteroidal, anti-inflammatory medications or corticosteroids.
- Easing skin itchiness with skin lotions and moisturizers.
- Slowing skin thickening and minimizing damage to the internal organs with medication that suppresses the immune system.
What is the best medicine for scleroderma?
The most promising drugs are mycophenolate mofetil or cyclophosphamide with or without antithymocyte globulin.
What viruses trigger scleroderma?
Suspected triggers for scleroderma include viral infections (especially cytomegalovirus), drugs (e.g. taxanes or bleomycin), and adhesive and coating materials or organic solvents (e.g. vinyl chloride or trichloroethylene).
Is scleromyxedema fatal?
Scleromyxedema is described as an unpredictable disease, but is usually progressive, debilitating, and lethal in the absence of a successful treatment. Death may result from complications with extracutaneous involvement or treatment side effects.
What is the latest treatment for scleroderma?
A clinical trial with a similar drug called iloprost has been recently completed. If the results of the phase III clinical trial demonstrate the medication is safe and effective, we are hoping this drug will gain FDA approval and may become available for all scleroderma patients across the U.S.
Can scleroderma go into remission?
Some patients may have a time when their condition stabilizes. During this time, your skin may improve, and the mobility could increase. This could be a short-term change or might even go into long-term remission.
What is the newest treatment for scleroderma?
Two drugs are currently FDA approved to treat lung scarring, or pulmonary fibrosis, that occurs as a result of scleroderma: nintedanib and tocilizumab.
Is there a therapeutic approach to scleromyxedema?
Abstract Importance: Scleromyxedema is a chronic disease with high morbidity and mortality and no definitive therapeutic guidelines. Objective: To review all available data on the efficacy and the safety of the available treatments of scleromyxedema and suggest a possible therapeutic approach.
What is scleroedema (scleredema)?
Scleroedema (American spelling scleredema) is a type of cutaneous mucinosis of unknown cause. Scleroedema should not be confused with ‘ scleroderma ’, in which the skin is fibrotic ( morphoea and systemic sclerosis ). Who gets scleroedema? Scleroedema affects adults. In many cases, people with scleroedema have an underlying systemic disease.
Is scleromyxedema a rare disease?
Scleromyxedema is a rare disease that usually affects middle-aged adults between the ages of 30 and 80 years with no race or sex predominance [1]. In a multicenter retrospective study of 30 patients with scleromyxedema, the mean age of affected patients was 59 years [1].
What is scleromyxedema (Arndt-Gottron disease)?
Scleromyxedema, also known as diffuse/generalized and sclerodermoid lichen myxedematosus or Arndt-Gottron disease, is a primary cutaneous mucinosis characterized by a generalized, papular and sclerodermoid, cutaneous eruption that usually occurs in association with monoclonal gammopathy [ 1 ].